Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Arbaclofen Placarbil MR Formulations in Healthy Volunteers
NCT03058237Phase 1Completed
- Sponsor
- Indivior
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of arbaclofen placarbil in alcohol use disorder (AUD) (14 arms), sponsored by Indivior. Primary endpoint: Time to Maximum Concentration. Started Jan 2017; status: completed.
02
Drugs
arbaclofen placarbil
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03058237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058237.